| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $67.5M | +25.2% |
| R&D Expense | $251.1M | +47.7% |
| SG&A Expense | $120.0M | +55.6% |
| Operating Income | -$303.6M | -57.2% |
| Pre-tax Income | -$278.4M | -61.9% |
| Income Tax | $297K | -85.3% |
| Net Income | -$278.7M | -60.2% |
| EPS (Basic) | -$3.18 | -57.4% |
| EPS (Diluted) | -$3.18 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $149.1M | -33.6% |
| Accounts Receivable | $8.8M | +327.4% |
| Inventory | $413K | — |
| Current Assets | $708.7M | -4.9% |
| Total Assets | $738.4M | -2.9% |
| Current Liabilities | $117.0M | +48.6% |
| Long-term Debt | $9.7M | +1.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.1M | -147.7% |
| Capital Expenditures | $6.6M | +1306.4% |
| Investing Cash Flow | -$13.1M | +87.1% |
| Financing Cash Flow | $1.8M | -98.8% |
| Free Cash Flow | -$70.7M | -152.8% |
| -57.4% |
| Total Liabilities |
| $564.2M |
| +62.8% |
| Stockholders' Equity | $174.1M | -57.9% |